MASCC Guidelines


> Search by Study Group

Antiemetics
Bone and Musculoskeletal
Cancer Pain (Palliative Care Subgroup)
Education
Fatigue
Geriatrics
Hemostasis
Immuno-Oncology (Neutropenia Subgroup)
Mucositis
Neurological Complications
Neutropenia, Infection & Myelosuppression
Nutrition and Cachexia
Oncodermatology
Oral Care
Palliative Care
Pediatrics
Psychosocial
Survivorship

 

Antiemetics Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy (2016 update) - UNDER REVISION
Dupuis LL et al. Support Care Cancer. 2016 Aug 10

MASCC/ESMO consensus recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential (2016 update) - UNDER REVISION
Olver I et al. Support Care Cancer. 2016 Aug 30

MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents (2016 update) - UNDER REVISION
Jordan K et al. Support Care Cancer. 2016 Aug 8

MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children (2016 update) - UNDER REVISION
Dupuis LL et al. Support Care Cancer. 2016 Aug 26

MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following high emetic risk chemotherapy (2016 update) - UNDER REVISION
Herrstedt J et al. Support Care Cancer. 2016 Jul 22

MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy (2016 update) - UNDER REVISION
Roila F et al. Support Care Cancer. 2016 Aug 11

MASCC/ESMO consensus recommendations: Prevention of radiotherapy-induced nausea and vomiting (2016 update) - UNDER REVISION
Ruhlmann CH et al. Support Care Cancer. 2016 Sep 13

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
Roila F et al. Support Care Cancer. 2016 Sep 14 

Guideline Summary Slide Set (2016 with updates 2019) - This summary slide set encompasses all of the publications above
Antiemetics in advanced cancer (MASCC updated guideline) - UPDATED
Davis M et al. Support Care Cancer. 2021 Aug 16
Guideline Summary Slide Set (2021) Guideline Summary (2021)
Nausea and vomiting in malignant bowel obstruction - UPDATED
Davis M et al. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer. 2021 Aug 14
Guideline Summary Slide Set (2021) Guideline Summary (2021)

 

Bone and Musculoskeletal Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
Yarom N et al. J Clin Oncol. 2019 Jul 22
Guideline Summary Slide Set (2019) Guideline Summary (2019)

 

Immuno-Oncology (Neutropenia Subgroup)

MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors
Rapoport BL et al. Support Care Cancer. 2020 Sep 4
Cancer immunotherapy–related adverse events: causes and challenges
Blidner AG et al. Support Care Cancer. 2020 Aug 28
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities
Cooksley T et al. Support Care Cancer. 2020 Aug 27
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
Suarez-Almazor ME et al. Support Care Cancer. 2020 Aug 27
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
Shannon VR et al. Support Care Cancer. 2020 Sep 3
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors
Choi J et al. Support Care Cancer. 2020 Aug 27
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors
Dougan M et al. Support Care Cancer. 2020 Aug 27

 

Mucositis Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






Guideline Summary Slide Set  (2019 with updates 2020) - This slide set encompasses all of the publications below
MASCC, Mucositis Study Group – mucositis guidelines – Summary 
Elad S et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Jul 28

MASCC, Mucositis Study Group – mucositis guidelines – Introduction to part 1
Elad S. The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines – Introduction to part 2
Elad S. The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions. Support Care Cancer. 2020 Feb 12

MASCC, Mucositis Study Group – mucositis guidelines – Methods 
Ranna V et al. Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines – Basic oral care
Hong CHL et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines – Photobiomodulation therapy / laser 
Zadik Y et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines – Anti-inflammatory agents 
Ariyawardana A et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines –– Natural and miscellaneous agents – Part 1
Yarom N et al. Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines –– Natural and miscellaneous agents – Part 2
Yarom N et al. Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. Support Care Cancer. 2020 Feb 13

MASCC, Mucositis Study Group – mucositis guidelines – Antimicrobials, mucosal coating agents, anesthetics, and analgesics
Saunders DP et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020 Feb 12

MASCC, Mucositis Study Group – mucositis guidelines – Cryotherapy
Correa MEP et al. Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019 Dec 14

MASCC, Mucositis Study Group – mucositis guidelines – Growth factors and cytokines
Logan RM et al. Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020 Feb 21

MASCC, Mucositis Study Group – mucositis guidelines – all interventions for GI mucositis
Bowen JM et al. Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – mucositis guidelines – sub-analysis: all interventions in pediatric patients
Miranda-Silva W et al. MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Support Care Cancer. 2020 Nov 6

MASCC, Mucositis Study Group – systematic review – pathogenesis
Bowen J et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019 Jul 8

MASCC, Mucositis Study Group – systematic review – risk prediction
Wardill HR et al. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020 Jun 26

 

Oncodermatology Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group - UNDER REVISION
Wong RKS et al. Support Care Cancer. 2013 Aug 14
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
Lacouture ME et al. Support Care Cancer. 2011 Jun 1
Guideline Summary Slide Set (2011)

 

Oral Care Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies (ISOO/MASCC/ASCO Guideline)
Mercadante V et al. Support Care Cancer. 2021 Sep 1
Guideline Summary Slide Set (2021) Guideline Summary (2021)

 

Palliative Care Study Group

DOWNLOAD GUIDELINES - click here   • MASCC resources are available for download by providing a valid email address.

MASCC MEMBERS -  CLICK HERE

NON-MEMBER ACCESS: (*indicates required fields )






Antiemetics in advanced cancer (MASCC updated guideline) - UPDATED
Davis M et al. Support Care Cancer. 2021 Aug 16
Guideline Summary Slide Set (2021) Guideline Summary (2021)
Nausea and vomiting in malignant bowel obstruction - UPDATED
Davis M et al. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer. 2021 Aug 14
Guideline Summary Slide Set (2021) Guideline Summary (2021)

Last Updated on Monday, October 04, 2021 02:49 PM